AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
Feb 14, 2017 12:03 pm UTC| Business
Recently approved first-of-its-kind, non-estrogen prescription therapy for a common symptom of menopause ...
AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
Feb 14, 2017 12:03 pm UTC| Business
Recently approved first-of-its-kind, non-estrogen prescription therapy for a common symptom of menopause ...
AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
Feb 14, 2017 12:03 pm UTC| Business
Recently approved first-of-its-kind, non-estrogen prescription therapy for a common symptom of menopause ...
Feb 14, 2017 12:02 pm UTC| Business
Six leading U.S. retinal surgery centers expected to participate as enrollment sites in the trialAnticipate beginning trial enrollment by mid-2017; interim trial update expected by the end of 2017 ROCKVILLE, Md., Feb. ...
Feb 14, 2017 12:02 pm UTC| Business
Six leading U.S. retinal surgery centers expected to participate as enrollment sites in the trialAnticipate beginning trial enrollment by mid-2017; interim trial update expected by the end of 2017 ROCKVILLE, Md., Feb. ...
Feb 14, 2017 12:02 pm UTC| Business
Six leading U.S. retinal surgery centers expected to participate as enrollment sites in the trialAnticipate beginning trial enrollment by mid-2017; interim trial update expected by the end of 2017 ROCKVILLE, Md., Feb. ...
Foothills Announces Drilling Results on its Labokay Well
Feb 14, 2017 12:02 pm UTC| Business
DENVER, Feb. 14, 2017 -- Foothills Exploration, Inc.(OTCQB:FTXP) (the “Company” or “Foothills”), an independent oil and gas exploration company engaged in the acquisition and development of oil and gas properties in the...